Atara Biotherapeutics Stock News

Short sellers have been raking it in on their Wirecard shorts, but most haven't cashed their positions out yet. Analysis from one firm shows

Two Sigma Investments LP decreased its holdings in shares of Atara Biotherapeutics Inc (NASDAQ:ATRA) by 66.3% in the first quarter, according to the company in its most recent Form 13F filing with the

Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transformative therapies for patients with severe diseases i

BNP Paribas Arbitrage SA grew its stake in Atara Biotherapeutics Inc (NASDAQ:ATRA) by 330.3% during the first quarter, according to the company in its most recent filing with the Securities and Exchan

In this article we will check out the progression of hedge fund sentiment towards Atara Biotherapeutics Inc (NASDAQ:ATRA) and determine whether it is a good investment right now. We at Insider Monkey

Atara Biotherapeutics, Inc. (Nasdaq:ATRA), a pioneer in T-cell immunotherapy leveraging its novel allogeneic EBV T-cell platform to develop transforma

Atara Biotherapeutics (ATRA) has seen solid earnings estimate revision activity over the past month, and belongs to a strong industry as well.

There’s a lot to be optimistic about in the Healthcare sector as 3 analysts just weighed in on Bioxcel Therapeutics

Maverick Capital Ltd. increased its holdings in shares of Atara Biotherapeutics Inc (NASDAQ:ATRA) by 4.9% in the 1st quarter, according to its most recent disclosure with the Securities and Exchange C

Ohio Gov. Mike DeWine signed the CARES Act statewide distribution into law on Friday (June 19). with Shaker City Council setting up the required Local Coronavirus Fund three days later.

The

Wellington Management Group LLP grew its position in Centurylink Inc (NYSE:CTL) by 599.8% in the first quarter, according to its most recent Form 13F filing with the Securities and Exchange Commission

Transport secretary intervenes over fate of 1,500 people stranded on five vessels

Equities analysts predict that Centurylink Inc (NYSE:CTL) will announce earnings of $0.33 per share for the current quarter, according to Zacks Investment Research. Four analysts have issued estimates

Alliancebernstein L.P. lifted its holdings in shares of Centurylink Inc (NYSE:CTL) by 5.1% in the 1st quarter, according to its most recent filing with the Securities and Exchange Commission. The firm